3-(1H-(1,2,3)三氮唑-4-基)-苯腈 | 550364-01-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 3-(1H-(1,2,3)三氮唑-4-基)-苯腈
• 中文别名: 3-(1H-1,2,3-噻唑-4-基)苯甲腈
• 英文名称: 3-(1H-1,2,3-triazol-4-yl)benzonitrile
• 英文别名: 3-(2H-triazol-4-yl)benzonitrile
• CAS: 550364-01-7
• 化学式: C₉H₆N₄
• 分子量: 170.173
• InChiKey: WTEOJKCYXGSBQC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  65.4
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2933990090
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H332,H335

反应信息

• 作为反应物：
  描述：

  三氟甲磺酸N-吡啶鎓 、 3-(1H-(1,2,3)三氮唑-4-基)-苯腈 在 sodium methylate 作用下， 以 甲醇 为溶剂， 反应 18.0h， 以20%的产率得到3-(1-Pyridin-2-yl-1H-[1,2,3]triazol-4-yl)-benzonitrile
  参考文献：
  名称：

  Discovery of Novel Heteroarylazoles That Are Metabotropic Glutamate Subtype 5 Receptor Antagonists with Anxiolytic Activity

  摘要：

  The highly potent, selective, and brain-penetrant metabotropic glutamate subtype 5 (mGlu5) receptor antagonists 3-(5-pyridin-2-yl-2H-tetrazol-2-yl)benzonitrile (47) and 3-fluoro-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)benzonitrile (48) are reported. Compound 47 is active in the rat fear-potentiated startle (FPS) model of anxiety with ED50 = 5.4 mg/kg (po) when dosed acutely. In this model the anxiolytic effects of 47 rapidly tolerate on repeated dosing.

  DOI：

  10.1021/jm049828c
• 作为产物：
  描述：

  3-氰基苯甲醛 在 叠氮基三甲基硅烷 、 4 A molecular sieve 、 甲基磺酰氯 、 二乙胺 、 三乙胺 作用下， 以 四氢呋喃 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 48.25h， 生成 3-(1H-(1,2,3)三氮唑-4-基)-苯腈
  参考文献：
  名称：

  Discovery of Novel Heteroarylazoles That Are Metabotropic Glutamate Subtype 5 Receptor Antagonists with Anxiolytic Activity

  摘要：

  The highly potent, selective, and brain-penetrant metabotropic glutamate subtype 5 (mGlu5) receptor antagonists 3-(5-pyridin-2-yl-2H-tetrazol-2-yl)benzonitrile (47) and 3-fluoro-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)benzonitrile (48) are reported. Compound 47 is active in the rat fear-potentiated startle (FPS) model of anxiety with ED50 = 5.4 mg/kg (po) when dosed acutely. In this model the anxiolytic effects of 47 rapidly tolerate on repeated dosing.

  DOI：

  10.1021/jm049828c

文献信息

• Direct Synthesis of 4-Aryl-1,2,3-triazoles via I₂-Promoted Cyclization under Metal- and Azide-Free Conditions
  作者：Chun Huang、Xiao Geng、Peng Zhao、You Zhou、Xiao-Xiao Yu、Li-Sheng Wang、Yan-Dong Wu、An-Xin Wu

  DOI：10.1021/acs.joc.1c01702

  日期：2021.10.1

  We herein report an iodine-mediated formal [2 + 2 + 1] cyclization of methyl ketones, p-toluenesulfonyl hydrazines, and 1-aminopyridinium iodide for preparation of 4-aryl-NH-1,2,3-triazoles under metal- and azide-free conditions. Notably, this is achieved using p-toluenesulfonyl hydrazines and 1-aminopyridinium iodide as azide surrogates, providing a novel route toNH-1,2,3-triazoles. Furthermore, this

  本文我们报告碘介导的正式[2 + 2 + 1]甲基酮，环化p甲苯磺酰肼，和1-氨基吡啶碘化物用于制备4-芳基- NH下金属-1,2,3-三唑和无叠氮化物条件。值得注意的是，这是使用对甲苯磺酰肼和碘化 1-氨基吡啶鎓作为叠氮化物替代物实现的，为NH -1,2,3-三唑提供了一条新途径。此外，这种方法提供了对吲哚胺 2,3-双加氧酶 (IDO) 的强效抑制剂的快速且实用的途径。
• Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5
  申请人：Cosford D.P. Nicholas

  公开号：US20050020585A1

  公开（公告）日：2005-01-27

  Triazole compounds substituted directly, or by a bridge, with a heteroaryl moiety containing N adjacent to the point of connection of the heteroaryl which are metabotropic glutamate receptor—subtype 5 (“mGluR5”) modulators useful in the treatment of psychiatric and mood disorders such as, for example, schizophrenia, anxiety, depression, bipolar disorder and panic, as well as in the treatment of pain, Parkinson's disease, cognitive dysfunction, epilepsy, circadian rhythm disorders, drug addiction, drug abuse, drug withdrawal and other diseases.

  直接或通过桥连基取代的三唑化合物，其杂环芳基团含有与杂环芳基连接点相邻的N，可作为代谢型谷氨酸受体亚型5（“mGluR5”）调节剂，用于治疗精神和情绪障碍，例如精神分裂症、焦虑症、抑郁症、双相障碍和惊恐症，以及用于治疗疼痛、帕金森病、认知功能障碍、癫痫、昼夜节律紊乱、药物成瘾、药物滥用、药物戒断和其他疾病。
• WO2021021761A5
  申请人：——

  公开号：WO2021021761A5

  公开（公告）日：2023-08-04
• Rational Design of 4-Aryl-1,2,3-Triazoles for Indoleamine 2,3-Dioxygenase 1 Inhibition
  作者：Ute F. Röhrig、Somi Reddy Majjigapu、Aurélien Grosdidier、Sylvian Bron、Vincent Stroobant、Luc Pilotte、Didier Colau、Pierre Vogel、Benoît J. Van den Eynde、Vincent Zoete、Olivier Michielin

  DOI：10.1021/jm300260v

  日期：2012.6.14

  Indoleamine 2,3-dioxygenase 1 (IDO1) is an important therapeutic target treatment of diseases such as cancer that involve pathological immune escape. Starting from the scaffold of our previously discovered IDO1 inhibitor 4-phenyl-1,2,3-triazole, we used computational structure-based methods to design more potent ligands. This approach yielded highly efficient low molecular weight inhibitors, the most active being of nanomolar potency both in an enzymatic and in a cellular assay, while showing no cellular toxicity and a high selectivity for IDO1 over tryptophan 2,3-dioxygenase (TDO). A quantitative structure-activity relationship based on the electrostatic ligand-protein interactions in the docked binding modes and on the quantum chemically derived charges of the triazole ring demonstrated a good explanatory power for the observed activities.
• Direct Synthesis of N-Unsubstituted 4-Aryl-1,2,3-triazoles Mediated by Amberlyst-15
  作者：Zu-Li Wang、Hui Zhang、Dao-Qing Dong

  DOI：10.1055/s-0035-1560488

  日期：——

  A highly efficient and effective method for the synthesis of N-unsubstituted 4-aryl-1,2,3-triazoles promoted by Amberlyst-15 is described. The promoter can be recycled and reused up to eight times without any reduction in its catalytic activity.